Fulgent Genetics, Inc.
—- Market cap
- —
- Debt
- +$476.00K
- Cash
- −$50.19M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FLGT stock price vs NFLX: inconclusive — current versus $963.27 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NFLX's multiple
Implied fair value · at FLGT's multiple
Needs FLGT P/S.
Close Dec 31, 2024
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FLGT FY 2025 (ended Dec 31, 2025) · NFLX FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 100% equity / 0% debt · EV / Revenue 82.26x · EV / EBITDA 276.52x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FULGENT GENETICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
NETFLIX INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.00x
0.54x
Net debt / EBITDA
Leverage against operating earnings
1.15x
0.40x
Cash and equivalents
Liquid reserves on the balance sheet
$50.19M
$9.06B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
FLGT vs NEO
Natera, Inc.
FLGT vs NTRA
Guardant Health, Inc.
FLGT vs GH
EXACT SCIENCES CORP
FLGT vs EXAS
OPKO HEALTH, INC.
FLGT vs OPK
Apple Inc.
FLGT vs AAPL
AMAZON COM INC
FLGT vs AMZN
COMCAST CORP
FLGT vs CMCSA
Walt Disney Co
FLGT vs DIS
Warner Bros. Discovery, Inc.
FLGT vs WBD
Live Nation Entertainment, Inc.
FLGT vs LYV
$476.00K
$14.46B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.